Literature DB >> 2051070

Strategies for optimized application of annular-phased-array systems in clinical hyperthermia.

P Wust1, J Nadobny, R Felix, P Deuflhard, A Louis, W John.   

Abstract

A theoretical framework is presented for optimized heating of deep-seated tumours by phase and amplitude steering. The optimization problem for a specific tumour and perfusion case results in a functional dependency between power-level and maximum obtainable therapeutic efficiency. Different optimization criteria and strategies are outlined, which cause an increase of power or thermal dose in the tumour. Three tumour models (central pelvic tumour, eccentric abdominal tumour with or without necrosis) are analysed in detail. The simulation studies predict that appreciable parts of these tumours (50-100%) can be heated efficiently (42.5-43 degrees C) within the range of available and clinically tolerated power levels (1-5 kW/m), if tumour perfusion is less than 20-25 ml/100 g min. Some improvements are obtained by increasing the number of independent channels (from four to eight) and by the application of time-dependent (complementary) power-deposition patterns.

Entities:  

Mesh:

Year:  1991        PMID: 2051070     DOI: 10.3109/02656739109004986

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  4 in total

1.  Improved hyperthermia treatment control using SAR/temperature simulation and PRFS magnetic resonance thermal imaging.

Authors:  Zhen Li; Martin Vogel; Paolo F Maccarini; Vadim Stakhursky; Brian J Soher; Oana I Craciunescu; Shiva Das; Omar A Arabe; Williams T Joines; Paul R Stauffer
Journal:  Int J Hyperthermia       Date:  2010-11-11       Impact factor: 3.914

2.  An RF phased array applicator designed for hyperthermia breast cancer treatments.

Authors:  Liyong Wu; Robert J McGough; Omar Ali Arabe; Thaddeus V Samulski
Journal:  Phys Med Biol       Date:  2005-12-15       Impact factor: 3.609

3.  Radio-frequency ring applicator: energy distributions measured in the CDRH phantom.

Authors:  G C van Rhoon; P Raskmark; S N Hornsleth; P M van den Berg
Journal:  Med Biol Eng Comput       Date:  1994-11       Impact factor: 2.602

Review 4.  Challenges to effective cancer nanotheranostics.

Authors:  Marites P Melancon; R Jason Stafford; Chun Li
Journal:  J Control Release       Date:  2012-08-18       Impact factor: 9.776

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.